Analysts estimates for $10 this year, but it all depends if the companies feel this stock is a guaranteed win to hit $10. If so they may not care what the price is right now and getting as many shares as they can under $10 this year.
I am hopeful to see $10 this year. After that maybe see accumulation around that point through next year until revenue and FDA provides more insight to drive us further. My dream is for CryoPort to get bought for $20+ a share ($30-$50Mil in rev), or reach that point separately. Either way I am not seeing any downside just general folks that want to take a bit off the top. Even then the volume has more that enough interest to absorb most of those.
And who knows we could see positive surprises that could change everything.
I too am concerned. I expect a pull back in coming days as we have attracted alot of swing traders and some shorts who only found us based on recent velocity. In the long run it doesn't matter and I need to keep telling myself that. Though I get annoyed when I add to my position and am hesitant whether I should exercise patience or pull the trigger
I think the future potential beyond 2018-2019 in CAR-T is what will drive us. If money managers see explosive potential, they will be less concerned that Cryoport only does 25mm next yr vs 35mm. As long as we remain the best of breed in this space we will get bettors siding with CYRX rather than trying to gamble on which CAR-T pharma companies will win out. As Smith on Stocks analogy goes, we are selling shovels and picks to gold miners. Quite a few of those miners are going to go home empty handed so why risk it.
News 
Market Data 
Discover 
